News

SAN FRANCISCO, Calif. – April 13, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its [...]

Boston, MA – March 31, 2021 (Journal of Precision Medicine) Multidimensional Predictive Diagnostics: The GPS of Clinical Practice Moving Beyond a Static Roadmap for Diagnostics By Natalie A. [...]

Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds Mar 16, 2021 | Molika Ashford NEW YORK – Cofactor Genomics has expanded the exploration of potential [...]

PROVIDENCE, R.I. – March 8, 2021 (Reportable News)– Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology by Women & [...]

February 2, 2021 (Drug Discovery & Development) What do cupcakes and Doppler radar have to do with oncology, and more specifically, predictive diagnostics? Before I explain, I’ll provide some [...]

December 15, 2020 (Clinical Researcher) Scientific and medical research is an investment in our future. We’re all keen to live long, healthy lives and most of us are willing to empower physicians [...]

November 10, 2020 (The Silicon Review) Cofactor Genomics is shortlisted in The Silicon Review’s 5 Best HealthTech Solution Providers to watch in 2020. See the listing and read more about [...]

October 19, 2020 (BioTechniques) Matching cancer patients to the therapies that provide the best chance of overcoming their disease is a difficult process, leading to a gap between the wealth of [...]

Contributed Commentary By Jarret Glasscock October 14, 2020 (DiagnosticsWorld) It has been said that the most dangerous phrase in business is, “We’ve always done it this way”. Believing that the [...]

September 23, 2020 (OncologyCentral) Title: Panel discussion: the past, present and future of immuno-oncology Duration: 1 hour This panel discussion, featuring experts from institutions across [...]